Plasmin enhances cell surface tissue factor activity in mesothelial and endothelial cells.
BACKGROUND
Mesothelial cells that line the thoracic cavity play an important role in maintaining the local balance between procoagulant and fibrinolytic activity, a role akin to the endothelial cells in blood vessels. The mechanism(s) responsible for increased tissue factor (TF) expression in mesothelial cells in response to injury are at present unclear.


OBJECTIVE
To investigate whether plasmin or thrombin, two major proteases that may be generated on the pleural surface upon injury, induce TF expression in human pleural mesothelial cells (HMC) and elucidate the underlying mechanism(s).


METHODS
Confluent monolayers of HMC and human umbilical vein endothelial cells (HUVEC) were exposed to plasmin or thrombin for varying time periods and TF expression was analyzed by measuring its activity in a factor Xa generation assay, TF antigen levels by immunoblot analysis and TF mRNA by Northern blot analysis.


RESULTS
Both plasmin and thrombin treatments increased cell surface TF activity in HMC by 3- to 4-fold. In contrast to thrombin, plasmin-induced TF activity is not dependent on the de novo synthesis of TF. In HUVEC, plasmin had a minimal effect on unperturbed HUVEC whereas it markedly increased TF activity of activated HUVEC. Plasmin treatment neither affected anionic phospholipid levels at the cell surface nor released protein disulfide isomerase, an oxidoreductase protein that was newly described to play a role in TF activation. Plasmin cleaved cell-associated TFPI.


CONCLUSIONS
Thrombin up-regulates TF activity in HMC through the transcriptional activation of TF whereas plasmin increases TF activity by inactivating the cell-associated TFPI by a limited proteolysis.
Kothari
H
H
Biomedical Research, The University of Texas Health Science Center, Tyler, TX 75708, USA.
Kaur
G
G
Sahoo
S
S
Idell
S
S
Rao
L V M
LV
Pendurthi
U
U
D002478:Cells, Cultured; D042783:Endothelial Cells / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000166:cytology; D004848:Epithelium / Q000378:metabolism*; D005341:Fibrinolysin / Q000494:pharmacology*; D006801:Humans; D008074:Lipoproteins / Q000037:antagonists & inhibitors; D010447:Peptide Hydrolases / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D013917:Thrombin / Q000494:pharmacology; D013925:Thromboplastin / Q000032:analysis* / Q000235:genetics*; D014158:Transcription, Genetic
D008074:Lipoproteins; D012333:RNA, Messenger; C051928:lipoprotein-associated coagulation inhibitor; D013925:Thromboplastin; D010447:Peptide Hydrolases; D013917:Thrombin; D005341:Fibrinolysin